Stockholders Equity and StockBased Compensation (Details Narrative) - USD ($)
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Dec. 03, 2021 |
Apr. 08, 2021 |
Mar. 09, 2020 |
Aug. 02, 2016 |
Nov. 19, 2021 |
Nov. 18, 2021 |
Oct. 29, 2021 |
Aug. 31, 2021 |
Oct. 21, 2019 |
Jan. 30, 2018 |
Sep. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Nov. 04, 2021 |
Jun. 30, 2021 |
Jun. 28, 2021 |
Mar. 25, 2021 |
Oct. 28, 2020 |
Dec. 31, 2019 |
Increased in common stock shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
188,588
|
|
|
|
13,500,000
|
|
|
|
Warrants outstanding, total |
|
|
|
|
|
|
|
|
|
|
|
|
45,577
|
70,361
|
|
|
|
|
|
|
Stock option exercise |
|
|
|
|
|
|
|
|
|
|
|
|
30,282
|
|
|
|
|
|
|
|
Stock option exercise net proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
|
|
|
|
|
|
|
Total unrecognized compensation cost |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,900,000
|
|
|
|
|
|
|
|
Increased in number of shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650,000
|
|
|
|
Convertible restricted stock |
|
|
|
|
|
|
|
|
|
|
|
|
188,588
|
243,800
|
|
|
|
|
|
|
Common stock, shares, outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
9,759,223
|
6,567,110
|
|
|
|
|
|
|
Total of common stock, outstanding shares |
|
|
|
|
|
|
|
|
|
|
|
|
7,035,510
|
4,216,568
|
|
|
|
|
|
|
Common stock, conversion basis |
|
|
|
|
|
|
|
|
|
|
|
|
The Series B Preferred Stock was initially convertible into 2,666,667 shares of common stock (convertible into 222,222 shares of common stock when adjusted for the one-for-twelve reverse stock split on October 21, 2019)
|
|
|
|
|
|
|
|
Class of Warrant or Right, Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
45,577
|
70,361
|
|
|
|
|
|
|
Stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
10,532,101
|
515,847
|
|
|
|
|
|
|
Weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
1 year 8 months 26 days
|
|
|
|
|
|
|
|
Preferred stock convertible amount |
|
|
|
|
|
|
|
|
|
|
|
$ 38,071
|
$ 213,720
|
$ 222,196
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
13,500,000
|
13,500,000
|
|
|
|
|
|
|
Fair value per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 12.92
|
$ 14.51
|
|
$ 12.66
|
|
|
|
$ 15.89
|
Incremental dilutive shares from equity instruments (treasury stock method) |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
9,759,223
|
6,567,110
|
|
|
|
|
|
|
Available-for-sale Securities [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agreement to sale of company's securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 75,000,000
|
|
|
Aggregate offering price |
|
|
|
|
$ 20,000,000.0
|
|
|
|
|
|
|
|
$ 9,000,000.0
|
|
|
|
|
|
|
|
Sold of ATM |
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000.0
|
3,300,000
|
|
|
|
|
|
|
Proceeds for sale of ATM |
|
|
|
|
|
|
|
|
|
|
|
|
$ 14,800,000
|
$ 12,300,000
|
|
|
|
|
|
|
Short-Term Non-Qualified Options [Member] | Advisory board members[Member] | Directors, Officers and Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price per shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.08
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.82
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
3 years 3 months 18 days
|
|
|
|
|
|
|
|
Term of options |
|
|
|
|
|
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price per shares |
|
|
|
|
|
|
|
|
|
|
|
|
$ 28.08
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 75.60
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
7 years 10 months 24 days
|
|
|
|
|
|
|
|
Term of options |
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
Maximum [Member] | Short-Term Non-Qualified Options [Member] | Employees, Consultants and Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 75.60
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
9 years 8 months 12 days
|
|
|
|
|
|
|
|
Maximum [Member] | Short-Term Non-Qualified Options [Member] | Advisory board members[Member] | Directors, Officers and Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Term of options |
|
|
|
|
|
|
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
Convertible Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock convertible amount |
|
|
|
$ 60,000
|
|
|
|
|
|
|
|
|
$ 6,200,000
|
|
|
|
|
|
|
|
Additional common shares |
|
|
|
|
|
|
|
|
|
|
|
|
64,398
|
20,980
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
|
|
|
|
|
|
|
|
222,222
|
|
|
|
222,222
|
|
|
|
|
|
|
|
Preferred Stock, Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
2,666,667
|
|
|
|
|
|
|
Rate of dividend payable in kind |
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
Price per shares |
|
|
|
|
|
|
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
2,666,667
|
|
|
0
|
2,666,667
|
|
|
|
|
|
|
Common stock equivalents shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
7,748,505
|
|
|
|
|
|
|
Accrued dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 897,518
|
|
|
|
|
|
|
Aggregate liquidation preference |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,600,000
|
|
|
|
|
|
|
|
Allocated amount |
|
|
|
|
|
|
|
|
|
|
|
|
$ 370,000
|
|
|
|
|
|
|
|
Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional common shares |
|
|
|
|
|
|
|
|
|
|
|
|
23,965
|
20,980
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
|
36,111
|
|
85,000
|
|
|
|
4,228
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
663,767
|
|
|
|
|
|
|
|
Accrete dividend |
|
|
|
$ 2.7451
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional deemed dividend |
|
|
|
$ 0.5699
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock shares reserved for future issuance, Value |
|
|
|
|
|
|
|
|
|
|
|
|
55,314
|
58,323
|
|
|
|
|
|
|
Convertible preferred stock, shares converted |
|
|
|
|
|
|
|
|
|
|
|
|
|
699,878
|
|
|
|
|
|
|
Accrued dividend |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 691,120
|
|
|
|
|
|
|
Series B Preferred Shares [Member] | Convertible Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
2,666,667
|
2,666,667
|
|
|
|
|
|
|
Allocated amount |
|
|
|
|
|
|
|
|
|
|
|
|
$ 37,000
|
|
|
|
|
|
|
|
Remaining value of warrant |
|
|
|
|
|
|
|
|
|
|
|
|
$ 30,000
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares, outstanding |
|
|
|
255,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock convertible amount |
|
|
|
$ 340,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value per share |
|
|
|
$ 39.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
|
|
|
$ 32.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
|
2,666,667
|
|
85,000
|
|
|
|
4,228
|
|
|
|
|
|
|
|
|
|
|
|
|
Rate of dividend payable in kind |
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Price per shares |
|
|
|
$ 2.75
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
1,020,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock shares reserved for future issuance, Value |
|
|
|
$ 280,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of beneficial conversion feature |
|
|
|
$ 280,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares reserved for future issuance |
|
|
|
1,020,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average market price of common stock |
|
|
|
$ 39.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, liquidation preference per share |
|
|
|
2.7451
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities Purchase Agreement [Member] | Series B Preferred Stock [Member] | Preferred Stock Equity Offerings [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value per share |
|
|
|
3.315
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
|
|
|
2.7451
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reverse stock split |
|
|
|
|
|
|
|
|
|
|
|
|
one-for-twelve reverse stock split on October 21, 2019
|
|
|
|
|
|
|
|
Accrete dividend |
|
|
|
$ 2.7451
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Measurement Input, Conversion Price [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
|
|
|
|
|
|
$ 10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
|
|
|
85,000
|
|
|
262,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Measurement Input, Conversion Price [Member] | Series B Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants outstanding, total |
|
|
|
|
|
|
|
|
|
55,555
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Outstanding |
|
|
|
|
|
|
|
|
|
55,555
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
|
|
|
|
|
|
|
|
|
$ 18
|
|
|
|
|
|
|
|
|
|
|
Rate of dividend payable in kind |
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
Price per shares |
|
|
|
|
|
|
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
2,666,667
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrants |
|
|
|
|
|
|
|
|
|
$ 400,000,000
|
|
|
|
|
|
|
|
|
|
|
Liquidation preference per share |
|
|
|
|
|
|
|
|
|
$ 1.50
|
|
|
|
|
|
|
|
|
|
|
Exchange of Outstanding Series A Convertible Preferred Stock for Common Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
|
|
|
|
|
|
$ 32.94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividend |
|
|
|
|
|
|
$ 800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
|
|
|
85,000
|
|
|
262,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional common stock shares issuable |
|
|
|
|
|
|
183,098
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing stock price |
|
|
|
|
|
|
$ 9.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital a deemed dividend |
|
|
|
|
|
|
$ 1,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liquidation value of common stock |
|
|
|
|
|
|
$ 2,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange of Outstanding Series B Convertible Preferred Stock for Common Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued of aggregate shares of common stock |
522,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price |
$ 18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued dividend |
$ 1,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Stock, Shares Converted into common stock |
232,111
|
|
|
85,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional common stock shares issuable |
5,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing stock price |
$ 7.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital a deemed dividend |
$ 1,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Outstanding |
2,666,667
|
|
|
|
|
|
|
|
|
|
|
|
|
2,666,667
|
|
|
|
|
|
|
Vested Stock Options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate intrinsic value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 225,000
|
$ 33,000
|
|
|
|
|
|
|
Non-vested stock options [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate intrinsic value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 238,000
|
$ 33,000
|
|
|
|
|
|
|
Weighted-average period |
|
|
|
|
|
|
|
|
|
|
|
|
2 years 21 days
|
|
|
|
|
|
|
|
Net unrecognized compensation cost |
|
|
|
|
|
|
|
|
|
|
|
|
$ 42,000
|
|
|
|
|
|
|
|
2020 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
350,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,333,333
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
350,000
|
|
|
|
Increase in number of shares |
|
|
650,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PIK [Member] | Series B, Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
663,767
|
699,878
|
|
|
|
|
|
|
Aggregate liquidation preference |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,600,000
|
|
|
|
|
|
|
|
Accumulated dividend |
|
|
|
|
|
|
|
|
|
|
|
|
234,000.00
|
$ 700,000
|
|
|
|
|
|
|
Description of deemed dividend |
|
|
|
|
|
|
the original $1.50 conversion price prior to the one-for-twelve reverse stock split on October 21, 2019 of the PIK dividends to the $2.34 commitment date fair value per share on January 30, 2018 indicated that each PIK dividend would accrete 0.84 of BCF as an additional deemed dividend for every $1.50 of PIK dividend accrued.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total deemed dividends |
|
|
|
|
|
|
|
|
|
|
$ 10,000
|
$ 28,000
|
29,000
|
|
|
|
|
|
|
|
PIK [Member] | Series A, Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated dividend |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,200,000
|
$ 900,000
|
|
|
|
|
|
|
Omnibus Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.69
|
|
RSUs granted, value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 656,000
|
|
RSUs granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
243,800
|
|
Weighted average recognition period |
|
|
|
|
|
|
|
|
|
|
|
|
2 months 12 days
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 9.93
|
$ 2.69
|
$ 6.74
|
|
|
|
|
|
Common shares vested |
|
|
|
|
|
|
|
|
|
|
|
|
35,304
|
|
157,233
|
|
300,000
|
|
|
|
Compensation expected to be expensed |
|
|
|
|
|
|
|
|
|
|
|
|
$ 43,313
|
|
$ 500,000
|
|
$ 400,000
|
|
|
|
Granted to executive officers |
|
|
|
|
|
|
|
|
|
|
|
|
78,617
|
|
70,265
|
|
157,233
|
|
243,800
|
|
Board of Directors Chairman [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issuances equity grant value |
|
|
|
|
|
$ 35,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional common shares |
|
|
|
|
|
19,644
|
|
|
|
|
|
|
|
20,980
|
|
|
|
|
|
|
Common shares equity grant price per shares |
|
|
|
|
|
$ 10.69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of common shares issuances |
|
|
|
|
|
There were 13,096 common shares issued to four directors that vested immediately upon issuance and the remaining 6,548 shares of common shares were issued to the two remaining directors that vested on January 1, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of Directors Chairman [Member] | Restricted Stock Awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares issuances equity grant value |
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
Additional common shares |
|
|
|
|
|
188,588
|
|
|
|
|
|
|
188,588
|
20,980
|
|
|
|
|
|
|
Common shares equity grant price per shares |
|
|
|
|
|
$ 10.69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of common shares issuances |
|
|
|
|
|
Therefore these 188,588 shares were included in the total outstanding common shares at December 31, 2021 and compensation expense recognized straight line over the three-year vesting period. A total of $0.1 million of compensation expense was recorded for the year ended December 31, 2021.
|
|
|
|
|
|
|
The Company will reassess the probability of achieving this performance condition at each reporting period in 2022 and record the approximately $2 million as an expense as well as include these performance-based RSA shares in the total outstanding common shares, if there is a change to its assessment that it is probable that this performance-condition will be met
|
|
|
|
|
|
|
|
Chief Executie Officer [Member] | Minimum [Member] | Short-Term Non-Qualified Options [Member] | Advisory board members[Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.82
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
3 years 3 months 18 days
|
|
|
|
|
|
|
|
Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.82
|
|
|
|
|
|
|
|
Total fair value of stock options |
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
Common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
7,382
|
|
|
|
|
|
|
|
Exercise price lower range limit |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2.08
|
|
|
|
|
|
|
|
Exercise price upper range limit |
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.75
|
|
|
|
|
|
|
|
Non-qualified stock options granted |
|
|
|
|
|
|
|
|
|
|
|
|
206,087
|
|
|
|
|
|
|
|
Consultants [Member] | Maximum [Member] | Short-Term Non-Qualified Options [Member] | Advisory board members[Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 1.50
|
|
|
$ 75.60
|
|
|
|
|
|
|
|
Maturity date |
|
|
|
|
|
|
|
|
|
January 30, 2021
|
|
|
|
|
|
|
|
|
|
|
Chief Executive Officer [Member] | Maximum [Member] | Short-Term Non-Qualified Options [Member] | Advisory board members[Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contractual lives |
|
|
|
|
|
|
|
|
|
|
|
|
9 years 10 months 24 days
|
|
|
|
|
|
|
|
Non-qualified stock options granted |
|
|
|
|
|
|
|
|
|
|
|
|
362,908
|
|
|
|
|
|
|
|
Non-qualified stock options outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
127,299
|
|
|
|
|
|
|
|
Four Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RSUs granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,200
|
|
Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incremental dilutive shares from equity instruments (treasury stock method) |
|
|
|
|
|
|
|
|
|
|
|
|
|
49,862
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
538,713
|
6,567,110
|
86,968
|
|
10,462
|
|
|
|